Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Congestive Ophthalmopathy

imatinib mesylate has been researched along with Congestive Ophthalmopathy in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dalm, VA; Dik, WA; Hirankarn, N; Paridaens, D; van den Bosch, WA; van Hagen, PM; Virakul, S1
Dik, WA; Dingjan, GM; Drexhage, HA; Hooijkaas, H; Paridaens, D; Schrijver, B; van Daele, PL; van den Bosch, WA; van Hagen, PM; van Steensel, L1
Dik, WA; Dingjan, GM; Drexhage, HA; Hooijkaas, H; Kuijpers, RW; Paridaens, D; van Daele, PL; van den Bosch, WA; van Hagen, PM; van Steensel, L1
Dik, WA; Drexhage, HA; Hooijkaas, H; Kuijpers, RW; Paridaens, D; van den Bosch, WA; van Hagen, PM; van Steensel, L1
Dik, WA; Drexhage, HA; Hooijkaas, H; Kuijpers, RW; Paridaens, D; van den Bosch, WA; van Hagen, PM; van Meurs, M; van Steensel, L1
Fratianni, C; Gonzales, M; Khardori, R; Mamillapali, C1

Reviews

1 review(s) available for imatinib mesylate and Congestive Ophthalmopathy

ArticleYear
Immunotherapy in miscellaneous medical disorders Graves ophthalmopathy, asthma, and regional painful syndrome.
    The Medical clinics of North America, 2012, Volume: 96, Issue:3

    Topics: Allergens; Anti-Asthmatic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antioxidants; Asthma; Azathioprine; Benzamides; Complex Regional Pain Syndromes; Cyclosporine; Decompression, Surgical; Etanercept; Glucocorticoids; Graves Ophthalmopathy; Humans; Imatinib Mesylate; Immunoglobulin G; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Octreotide; Omalizumab; Orbit; Piperazines; Pyridones; Pyrimidines; Radiotherapy Dosage; Receptors, Tumor Necrosis Factor; Risk Factors; Rituximab; Selenium

2012

Other Studies

5 other study(ies) available for imatinib mesylate and Congestive Ophthalmopathy

ArticleYear
The tyrosine kinase inhibitor dasatinib effectively blocks PDGF-induced orbital fibroblast activation.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2014, Volume: 252, Issue:7

    Topics: Becaplermin; Benzamides; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Dasatinib; Dose-Response Relationship, Drug; Fibroblasts; Gene Expression Regulation; Glucuronosyltransferase; Graves Ophthalmopathy; Humans; Hyaluronan Synthases; Imatinib Mesylate; Interleukin-6; Interleukin-8; Orbit; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-sis; Pyrimidines; RNA, Messenger; Thiazoles

2014
Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy.
    Investigative ophthalmology & visual science, 2009, Volume: 50, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Becaplermin; Benzamides; Cell Proliferation; Cells, Cultured; Female; Fibroblasts; Gene Expression Regulation; Glucuronosyltransferase; Graves Ophthalmopathy; Humans; Hyaluronan Synthases; Hyaluronic Acid; Imatinib Mesylate; Male; Middle Aged; Orbit; Phosphorylation; Piperazines; Platelet-Derived Growth Factor; Polymerase Chain Reaction; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-sis; Pyrimidines; Receptors, Platelet-Derived Growth Factor; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta1

2009
Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy.
    Investigative ophthalmology & visual science, 2010, Volume: 51, Issue:2

    Topics: Adult; Aged; Angiogenesis Inducing Agents; Becaplermin; Benzamides; Cells, Cultured; Cytokines; Electrophoretic Mobility Shift Assay; Enzyme-Linked Immunosorbent Assay; Female; Fibroblasts; Graves Ophthalmopathy; Humans; Imatinib Mesylate; Lung; Male; Middle Aged; NF-kappa B; Orbit; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-sis; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Skin

2010
Whole orbital tissue culture identifies imatinib mesylate and adalimumab as potential therapeutics for Graves' ophthalmopathy.
    The British journal of ophthalmology, 2011, Volume: 95, Issue:5

    Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzamides; Female; Gene Expression Regulation; Graves Ophthalmopathy; Humans; Hyaluronic Acid; Imatinib Mesylate; Interleukin-6; Male; Piperazines; Pyrimidines; RNA, Messenger; Tissue Culture Techniques; Tumor Necrosis Factor-alpha

2011
Orbit-infiltrating mast cells, monocytes, and macrophages produce PDGF isoforms that orchestrate orbital fibroblast activation in Graves' ophthalmopathy.
    The Journal of clinical endocrinology and metabolism, 2012, Volume: 97, Issue:3

    Topics: Benzamides; Cell Proliferation; Eye; Fibroblasts; Graves Ophthalmopathy; Humans; Hyaluronic Acid; Imatinib Mesylate; Interleukin-6; Macrophages; Mast Cells; Monocytes; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Pyrimidines

2012